Stevanovic Ana, Rossaint Rolf, Fritz Harald G, Froeba Gebhard, Heine Joern, Puehringer Friedrich K, Tonner Peter H, Coburn Mark
From the Department of Anaesthesiology, University Hospital RWTH Aachen, Aachen (AS, RR, MC), Department of Anaesthesiology and Intensive Care Medicine, Martha-Maria Hospital, Halle (HGF), Department of Anaesthesiology, University Hospital Ulm, Ulm (GF), Department of Anaesthesiology and Intensive Care Medicine, Harzklinik Hospital, Goslar (JH), Department of Anaesthesiology and Intensive Care Medicine, Klinikum am Steinenberg, Reutlingen (FKP), and Department of Anaesthesiology and Intensive Care Medicine, Klinikum Links der Weser, Bremen, Germany (PHT).
Eur J Anaesthesiol. 2015 Feb;32(2):106-16. doi: 10.1097/EJA.0000000000000183.
Desflurane's short emergence time supports fast track anaesthesia. Data on the rate of upper airway complications and emergence time when desflurane is used with laryngeal mask airway (LMA) are controversial and limited.
To compare recovery time variables and the rates of upper airway adverse events in patients with an LMA undergoing general surgery with desflurane, sevoflurane, isoflurane or propofol anaesthesia.
A systematic review and meta-analysis of randomised controlled trials (RCTs).
A systematic search for eligible RCTs in Embase (Elsevier) and in PubMed (National Library of Medicine) databases up to September 2013.
RCTs investigating the rates of cough overall, cough at emergence, laryngospasm, time to eye opening, time to removal of the LMA, time to respond to command and time to state date of birth in patients with an LMA, during emergence from desflurane, sevoflurane, isoflurane or propofol anaesthesia.
Thirteen RCTs were included and analysed. We found a strong interstudy variability. There was no difference in the rates of upper airway events between desflurane and sevoflurane or between desflurane and a control group consisting of all the other anaesthetics combined. Comparing desflurane (n = 284) with all other anaesthetic groups (n = 313), the risk ratio [95% confidence interval (95% CI)] was 1.12 (0.63 to 2.02, P = 0.70). Cough at emergence was only measured in patients receiving desflurane (n = 148) and sevoflurane (n = 146): the risk ratio (95% CI) was 1.49 (0.55 to 4.02, P = 0.43). Laryngospasm was rare and there was no significant difference in its incidence when desflurane (n = 262) was compared with all other anaesthetics combined (n = 289; risk ratio 1.03; 95% CI 0.33 to 3.20, P = 0.96). The times of all emergence variables were significantly faster in the desflurane group than in all other groups.
When using an LMA, upper airway adverse reactions in association with desflurane anaesthesia were no different from those noted with sevoflurane, isoflurane or propofol anaesthesia. Emergence from general anaesthesia with desflurane is significantly faster than all the other anaesthetics. Due to interstudy variations and the small size of the trials, further large-scale, multicentre studies are required to confirm or refute the results of this meta-analysis.
地氟烷的苏醒时间短,有利于实施快通道麻醉。关于地氟烷与喉罩气道(LMA)联合使用时上呼吸道并发症发生率及苏醒时间的数据存在争议且有限。
比较接受地氟烷、七氟烷、异氟烷或丙泊酚麻醉并使用LMA的普外科手术患者的恢复时间变量及上呼吸道不良事件发生率。
对随机对照试验(RCT)进行系统评价和荟萃分析。
截至2013年9月,在Embase(爱思唯尔)和PubMed(美国国立医学图书馆)数据库中系统检索符合条件的RCT。
研究在接受地氟烷、七氟烷、异氟烷或丙泊酚麻醉苏醒期使用LMA的患者中,总体咳嗽发生率、苏醒时咳嗽发生率、喉痉挛、睁眼时间、拔除LMA时间、对指令做出反应时间及说出出生日期时间的RCT。
纳入并分析了13项RCT。我们发现研究间存在很大差异。地氟烷与七氟烷之间或地氟烷与由所有其他麻醉药联合组成的对照组之间,上呼吸道事件发生率无差异。将地氟烷组(n = 284)与所有其他麻醉组(n = 313)进行比较,风险比[95%置信区间(95%CI)]为1.12(0.63至2.02,P = 0.70)。仅在接受地氟烷(n = 148)和七氟烷(n = 146)的患者中测量了苏醒时咳嗽:风险比(95%CI)为1.49(0.55至4.02,P = 0.43)。喉痉挛很少见,将地氟烷组(n = 262)与所有其他麻醉药联合组(n = 289)进行比较时,其发生率无显著差异(风险比1.03;95%CI 0.33至3.20,P = 0.96)。地氟烷组所有苏醒变量的时间均显著快于所有其他组。
使用LMA时,地氟烷麻醉相关的上呼吸道不良反应与七氟烷、异氟烷或丙泊酚麻醉时无差异。地氟烷全身麻醉苏醒明显快于所有其他麻醉药。由于研究间存在差异且试验规模较小,需要进一步开展大规模、多中心研究来证实或反驳该荟萃分析的结果。